(Q44062505)

English

NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jidong Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hiroyasu Imanishi

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yoshiki Amuro

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Toshikazu Hada

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

755-761

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Sulindac sulfide inhibits Ras signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Adenomatous polyposis coli, protein kinases, protein tyrosine phosphatase: the effect of sulindac

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

PCNA: structure, functions and interactions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Requirement of proliferating cell nuclear antigen in RAD6-dependent postreplicational DNA repair

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Evidence for involvement of yeast proliferating cell nuclear antigen in DNA mismatch repair

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10409

21 January 2018

Identifiers

10.1002/IJC.10409

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44062505&oldid=2164746499"